|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
52781230
線上人數 :
556
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"wang hp"的相關文件
顯示項目 111-135 / 255 (共11頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2005 |
From pharmacovigilance to vigilance planning- the system building for drug safety in Taiwan
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2005 |
Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma
|
陳志榮; Kuo SH; Chen LT; Chen CL; Doong SL; Yeh KH; Wu MS; Mao TL; Hsu HC; Wang HP; Lin JT; Cheng AL |
| 高雄醫學大學 |
2005 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
|
陳立宗;林肇堂;許博翔;詹昌明;王文明;王蒼恩;鄭安理 ; Chen LT;Lin JT;Tai JJ;Chen GH;Yeh HZ;Yang SS;Wang HP;Kuo SH;Sheu BS;Jan CM;Wang WM;Wang TE;Wu CW;Chen CL;Su IJ;Whang-Peng J;Cheng AL |
| 高雄醫學大學 |
2005 |
Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma.
|
陳立宗; Kuo SH;Chen LT;Chen CL;Doong SL;Yeh KH;Wu MS;Mao TL;Hsu HC;Wang HP;Lin JT;Cheng AL |
| 國立臺灣大學 |
2004-12 |
nterleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.
|
Huang, SP; Wu, MS; Shun, CT; Wang, HP; Lin, MT; Kuo, ML; Lin, JT |
| 國家衛生研究院 |
2004-07-10 |
Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma
|
Wu, MS; Chen, LT; Shun, CT; Huang, SP; Chiu, HM; Wang, HP; Lin, MT; Cheng, AL; Lin, JT |
| 國立臺灣大學 |
2004-07 |
Right-sided aorta with Kommerell’s diverticulum.
|
Chiu, HM; Lin, JT; Chang, YC; Chang, YT; Tsai, MC; Wang, HP |
| 臺北醫學大學 |
2004 |
台灣用藥安全的風險管理體系
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
ADME-driven design of NME
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
The Campaign for Drug-Free-Teenagers via Education in Elementary schools
|
王惠珀; Wang HP; Kuo JH |
| 臺北醫學大學 |
2004 |
Introduction of APEC NPRS
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical regulation of biotech product toward international harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical Regulation Toward global Harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
The Current ADR Reporting System and Pharmacovigilance in Taiwan
|
王惠珀; Huang YW; Hsu CW; Wang HP; |
| 臺北醫學大學 |
2004 |
IND & NDA
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
生技製藥領域政策之現況與未來趨勢
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Public Education on Rational Drug Use
|
王惠珀; Wang HP; Hsiu MM |
| 臺北醫學大學 |
2004 |
Introduction of APEC NPRS
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical regulation of biotech product toward international harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
EU-Taiwan technical cooperation program on medical devices
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical Regulation Toward global Harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
IND & NDA
|
王惠珀; Wang HP |
| 國立臺灣大學 |
2004 |
Unsualy sonographic appearance of a gastrointestinal stromal tumor presenting as a large multilocular cystic mass
|
Chang, CY; Wang, HP; Mao, TL; Hu, RH; Yang, PM; Lai, MY; Lin, JT |
| 臺北醫學大學 |
2003 |
D-Phenylglycine-L-Dopa as an Intrinsic Slow Dopamine-releasing Prodrug
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Clinical trials in Taiwan: Regulatory achievements and current status
|
王惠珀; Wang HP; Chen SY |
顯示項目 111-135 / 255 (共11頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目
|